These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 171062
21. [Examples of biochemical lesions in the loss of hormone dependence in thyroid tumors]. Macchia V, Mariano A. Minerva Med; 1986 Nov 17; 77(44):2035-8. PubMed ID: 3785716 [No Abstract] [Full Text] [Related]
22. Exposure of thyroid slices to thyroid-stimulating hormone induces refractoriness of the cyclic AMP system to subsequent hormone stimulation. Shuman SJ, Zor U, Chayoth R, Field JB. J Clin Invest; 1976 May 17; 57(5):1132-41. PubMed ID: 177452 [Abstract] [Full Text] [Related]
23. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes. Hoermann R, Amir SM, Ingbar SH. Endocrinology; 1988 Sep 17; 123(3):1535-43. PubMed ID: 3402396 [Abstract] [Full Text] [Related]
24. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland]. Shpakov AO, Shpakova EA, Tarasenko II, Derkach KV. Tsitologiia; 2014 Sep 17; 56(7):526-35. PubMed ID: 25696997 [Abstract] [Full Text] [Related]
25. Inhibitory effect of dietary iodine on the thyroid adenylate cyclase response to thyrotropin in the hypophysectomized rat. Rapoport B, West MN, Ingbar SH. J Clin Invest; 1975 Aug 17; 56(2):516-9. PubMed ID: 168233 [Abstract] [Full Text] [Related]
26. Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue. Field JB, Bloom G, Chou MC, Kerins ME, Larsen PR, Kotani M, Kariya T, Dekker A. J Clin Endocrinol Metab; 1978 Nov 17; 47(5):1052-8. PubMed ID: 233688 [Abstract] [Full Text] [Related]
28. Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system. Amr S, Menezez-Ferreira M, Shimohigashi Y, Chen HC, Nisula B, Weintraub BD. J Endocrinol Invest; 1985 Dec 17; 8(6):537-41. PubMed ID: 3009595 [Abstract] [Full Text] [Related]
29. Polyphloretin phosphate, an antagonist of thyrotropin action: evidence for an interaction with the hormone rather than the receptor. Amir SM, Kasagi K, Corretti M, Blank M, Ingbar SH. Endocrinology; 1985 Sep 17; 117(3):860-8. PubMed ID: 2990874 [Abstract] [Full Text] [Related]
30. Interaction of human chorionic gonadotropin and human luteinizing hormone with human thyroid membranes. Carayon P, Lefort G, Nisula B. Endocrinology; 1980 Jun 17; 106(6):1907-16. PubMed ID: 6245856 [Abstract] [Full Text] [Related]
31. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues. Duh QY, Siperstein AE, Miller RA, Smeds S, Clark OH. Surgery; 1989 Dec 17; 106(6):967-73; discussion 973-4. PubMed ID: 2588124 [Abstract] [Full Text] [Related]
32. Regulation of thyrotropin (TSH) release and production in monolayer cultures of transplantable TSH-producing mouse tumors. Eto S, Fleischer N. Endocrinology; 1976 Jan 17; 98(1):114-22. PubMed ID: 174885 [Abstract] [Full Text] [Related]
33. Relationship of gangliosides to the structure and function of thyrotropin receptors: their absence on plasma membranes of a thyroid tumor defective in thyrotropin receptor activity. Fishman PH, Aloj SM, Kohn LD, Brady RO. Proc Natl Acad Sci U S A; 1976 Nov 17; 73(11):4060-4. PubMed ID: 186783 [Abstract] [Full Text] [Related]
35. Studies of thyroid-stimulating hormone binding to bovine thyroid plasma membranes. Kotani M, Kariya T, Field JB. Metabolism; 1975 Aug 17; 24(8):959-71. PubMed ID: 1143091 [Abstract] [Full Text] [Related]
36. Separation and analysis of two plasma membrane fractions from bovine thyroid which differ in TSH binding and TSH activation of adenylate cyclase. Champier J, Munari-Silem Y, Alquier C, Audebet C, Rousset B. Mol Cell Endocrinol; 1985 Nov 17; 43(1):83-93. PubMed ID: 2998909 [Abstract] [Full Text] [Related]
37. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms. Clark OH, Gerend PL. J Clin Endocrinol Metab; 1985 Oct 17; 61(4):773-8. PubMed ID: 2993348 [Abstract] [Full Text] [Related]
38. Coupling defect of thyrotropin receptor and adenylate cyclase in a pseudohypoparathyroid patient. Mallet E, Carayon P, Amr S, Brunelle P, Ducastelle T, Basuyau JP, de Menibus CH. J Clin Endocrinol Metab; 1982 May 17; 54(5):1028-32. PubMed ID: 6277985 [Abstract] [Full Text] [Related]
39. Thyrotropin binding to rat thyroid membranes: reduced capacity associated with goitrogenesis. Witte A, Henderson B, Zakarija M, McKenzie JM. Endocrinology; 1980 May 17; 106(5):1489-97. PubMed ID: 6244933 [Abstract] [Full Text] [Related]
40. Influence of cholera toxin on in vitro refractoriness to thyrotropin of thyroids from rats fed propylthiouracil. Zakarija M, Witte A, McKenzie JM. Endocrinology; 1980 Dec 17; 107(6):2045-50. PubMed ID: 6253287 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]